Faculty Research 1990 - 1999

Title

The flaky skin (fsn) mutation in mice: map location and description of the anemia.

Document Type

Article

Publication Date

1995

Keywords

Animal, Animals-Newborn, Chromosome-Mapping, Duodenum: me, pa, Female, Genes-Recessive, Hematopoiesis, Hyperplasia, Iron: df, me, Liver: pa, Male, Mice, Mice-Inbred-A, Mice-Mutant-Strains: ge, Mice-SCID, Phenotype, Pyloric-Antrum: pa, Skin-Diseases-Papulosquamous: ge, Spleen: pa, SUPPORT-U-S-GOVT-P-H-S

JAX Source

Blood 1995 Oct 15;86(8):3220-6

Grant

AR40324/AR/NIAMS, CA42363/CA/NCI, RR08911/RR/NCRR

Abstract

Flaky skin (gene symbol fsn) is an autosomal recessive mutation that causes pleiotropic effects of anemia, papulosquamous skin disorder, and gastric forestomach hyperplasia. In this report, we assign fsn to distal chromosome 17 and characterize the anemia. The decrease in hematocrit levels and red blood cell counts is significant and persists throughout life in fsn/fsn mice. There is compensatory enlargement of the heart, liver, and spleen by 8 weeks of age, whereas the thymus is less than one half normal weight. Nucleated cell counts in the peripheral blood are increased 15- to 30-fold, primarily due to an increased percentage of normoblasts. The fsn/fsn mice examined at 8 weeks of age have significantly increased reticulocyte counts and protoporphyrin levels but reduced hemoglobin concentration, suggesting possible abnormalities of hemoglobin metabolism. Erythrocyte membrane fragility is normal. Compared with normal +/? littermates, fsn/fsn mice (1) lack splenic and hepatic stores of elemental iron, (2) have the ability to transport 59Fe across the duodenal cells and into the blood, (3) have increased levels of transferrin in serum, and (4) have acute loss of urinary 59Fe. Hemolysis is indicated by increased serum bilirubin and high blood reticulocyte numbers. Collectively, the genetic, hematologic, and pathologic data indicate a severe hematologic disorder caused by homozygosity for the fsn mutation that differs from other known hematologic mutations in the mouse. The mechanism whereby fsn induces the reported pleiotropic effects has yet to be elucidated.